Lee et al. (2018) demonstrated that INCB059872 reduced the migration of TN breast cancer cells, significantly reduced MSDC infiltration of the primary tumor and lung associated with a reduction in circulating CCL2, corresponding to a decrease in metastatic lung foci [117]. Here, CCL2 is linked to breast carcinoma.